Publications & Works

Publication Network
Articles 39
All (39)
SCI-E, SSCI, AHCI (35)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (1)
Scopus (33)
TRDizin (6)
Other Publications (2)

1. Assessment of Potential Side Effects Related To RAB27A Gene Therapy in Stem Cells.

Erol Ö. D., Şeker M. E., Şenocak Ş., Özbek N., Kılıç H. B., Kocaefe Y. Ç., et al.
Stem cell reviews and reports , 2025 (SCI-Expanded) identifier identifier

2. Development of optimized differentiation media for murine bone marrow multipotent mesenchymal stromal cells.

Pervin B., Şeker M. E., Gür S. N., Özbek N., Aerts-Kaya F. S. F.
Histochemistry and cell biology , vol.163, no.1, pp.81, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Obesity‐Induced Loss of Function of Bone Marrow Mesenchymal Stromal Cells Is Linked to Cellular Stress and Irreversible at Advanced Stages

Polat E. G., Şeker M. E., Pervin B., Ulum B., Aerts Kaya F. S. F.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE , vol.29, no.15, pp.1-11, 2025 (SCI-Expanded, Scopus) identifier identifier

4. Endocannabinoid system upregulates the enrichment and differentiation of human iPSC- derived spermatogonial stem cells via CB2R agonism

Gizer M., Onen S., Erol O. D., AERTS KAYA F. S. F., REÇBER T., NEMUTLU E., et al.
BIOLOGICAL RESEARCH , no.1, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Correction of Griscelli Syndrome Type 2 causing mutations in the RAB27A gene with CRISPR/Cas9

Erol Ö. D., Şenocak Ş., Özçimen Batman B., Güney Esken G., Kılıç H. B., Kocaefe Y. Ç., et al.
TURKISH JOURNAL OF BIOLOGY , vol.48, no.5, pp.290-298, 2024 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

6. Assessment of non‐myelotoxic agents as a preparatory regimen for hematopoietic stem cell gene therapy

Şeker M. E., Erol Ö. D., Pervin B., Wagemaker G., Van Til N. P., Aerts Kaya F. S. F.
HUMAN CELL , vol.38, no.9, pp.1-12, 2024 (SCI-Expanded)

7. Bone marrow mesenchymal stromal cells support regeneration of intestinal damage in a colitis mouse model, independent of their CXCR4 expression

Pervin B., Gizer M., Şeker M. E., Erol Ö. D., Gür S. N., Polat E. G., et al.
CLINICAL AND TRANSLATIONAL SCIENCE , vol.2024, no.17(5), pp.1-13, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. The Role of Rab GTPases in the development of genetic and malignant diseases.

Erol Ö. D., Şenocak Ş., Aerts-Kaya F. S. F.
Molecular and cellular biochemistry , vol.479, no.2, pp.255-281, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

9. Gene and Cellular Therapies for Leukodystrophies

Aerts Kaya F. S. F., Van Til N. P.
PHARMACEUTICS , vol.15, no.11, pp.1-25, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

10. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta

Sarikaya A., Aydin G., Ozyuncu Ö., Sahin E., Çetinkaya F. D., Aerts Kaya F. S. F.
BIOTECHNIC & HISTOCHEMISTRY , vol.97, no.2, pp.79-89, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

11. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients

Cagnan I., Keles M., Keskus A. G., Tombaz M., ŞAHAN Ö. B., AERTS KAYA F. S. F., et al.
HUMAN CELL , vol.35, no.1, pp.111-124, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

12. Modelling of rare diseases with induced pluripotent stem cells

Erol Ö. D., Şeker M. E., Aerts Kaya F. S. F.
Türkiye Klinikleri Tıbbi Genetik - Kök Hücre ve Rejeneratif Tıp , vol.1, pp.10-17, 2021 (TRDizin)

13. Effects of storage media, supplements and cryopreservation methods on quality of stem cells

Erol O. D., Pervin B., Seker M. E., Aerts-Kaya F. S. F.
WORLD JOURNAL OF STEM CELLS , vol.13, no.9, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

14. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.

Güney-Esken G., Erol Ö. D., Pervin B., Gürhan Sevinç G., Önder T., Bilgiç E., et al.
Stem cell research & therapy , vol.12, no.1, pp.287, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

15. Strategies to Protect Hematopoietic Stem Cells from Culture-Induced Stress Conditions.

Aerts-Kaya F. S. F.
Current stem cell research & therapy , vol.16, pp.755-770, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

16. CXCR4 expression by mesenchymal stromal cells is lost after use of enzymatic dissociation agents, but preserved by use of non-enzymatic methods.

Pervin B., Aydın G., Visser T., Uçkan-Çetinkaya D., Aerts-Kaya F. S. F.
International journal of hematology , vol.113, pp.5-9, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

17. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

Köse S., Aerts-Kaya F. S. F., Uçkan Çetinkaya D., Korkusuz P.
Advances in experimental medicine and biology , vol.1347, pp.135-162, 2021 (SCI-Expanded, Scopus) identifier identifier

18. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.

Aerts-Kaya F. S. F., Kilic E., Köse S., Aydin G., Cagnan I., Kuskonmaz B. B., et al.
Cytokine , vol.139, pp.155407, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

19. SUL-109 Protects Hematopoietic Stem Cells from Apoptosis Induced by Short-Term Hypothermic Preservation and Maintains Their Engraftment Potential.

Aerts-Kaya F. S. F., Visser T., Pervin B., Mammadova A., Özyüncü Ö., Wagemaker G., et al.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , vol.26, no.4, pp.634-642, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

20. Neuropeptide Y is involved in the regulation of quiescence of hematopoietic stem cells

Ulum B., Mammadova A., Özyüncü Ö., Uckan-Cetinkaya D., Yanık T., Aerts-Kaya F. S. F.
NEUROPEPTIDES , vol.80, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

21. Neurological Regulation of the Bone Marrow Niche

Aerts-Kaya F. S. F., Ulum B., Mammadova A., Köse S., Aydin G., Korkusuz P., et al.
CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 6: STEM CELLS: THEIR HETEROGENEITY, NICHE AND REGENERATIVE POTENTIAL , vol.1212, pp.127-153, 2020 (SCI-Expanded, Scopus) identifier identifier

22. Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases and Its Implications for Future Gene Therapy Trials in Turke

Güney E. G., Erol Ö. D., AERTS KAYA F. S. F.
Trakya University Journal of Natural Sciences , vol.20, pp.17-32, 2020 (ESCI, TRDizin) Creative Commons License

23. Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)

Kose S., Aerts Kaya F. S. F., Kuskonmaz B. B., Uckan Cetinkaya D.
TURKISH JOURNAL OF BIOLOGY , vol.43, no.3, pp.171-178, 2019 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

24. Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired

ULUM B. B., TEKER H. T., SARIKAYA A., BALTA G., Kuskonmaz B., UCKAN-CETINKAYA D., et al.
JOURNAL OF CELLULAR PHYSIOLOGY , vol.233, no.11, pp.8429-8436, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

25. B lymphocyte subsets and outcomes in patients with an initial diagnosis of transient hypogammaglobulinemia of infancy

Eroglu F. K., Kaya F. S. F., Cagdas D. N., Ozgur T. T., Yılmaz T., Tezcan I., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.88, no.4, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

26. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+cell numbers

Aerts-Kaya F. S. F., Koca G., Sharafi P., Sayla F. C., Uckan-Cetinkaya D., Ozdemir E.
BONE MARROW TRANSPLANTATION , vol.53, no.9, pp.1225-1227, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

27. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-beta 1 Production

CAGNAN I., GUNEL-OZCAN A., AERTS-KAYA F. S. F., Ameziane N., Kuskonmaz B., Dorsman J., et al.
STEM CELL REVIEWS AND REPORTS , vol.14, no.3, pp.425-437, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

28. Bone Marrow Mesenchymal Stem Cells from Donors with a High BMI Display ER Stress and Are Functionally Impaired.

Ulum B., Teker H. T., Sarıkaya A., BALTA G., KUŞKONMAZ B. B., ÇETİNKAYA F. D., et al.
JOURNAL OF CELLULAR PHYSIOLOGY , vol.2018, pp.1-8, 2018 (SCI-Expanded, Scopus)

29. Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation

KOSE S., AERTS-KAYA F. S. F., Kopru C. Z., NEMUTLU E., Koskonmaz B., KARAOSMANOĞLU B., et al.
EXPERIMENTAL HEMATOLOGY , vol.57, pp.30-41, 2018 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

30. Göbek kordon kanı hayat kurtarabilir atmayın, bağışlayın!

AERTS KAYA F. S. F.
Bilim ve Utopya , vol.24, no.284, pp.26-30, 2018 (Non Peer-Reviewed Journal)

31. Stably expressed reference genes during differentiation of bone marrow-derived mesenchymal stromal cells

Cagnan I., Aerts Kaya F. S. F., Uckan D., Gunel Ozcan A.
TURKISH JOURNAL OF BIOLOGY , vol.41, no.1, pp.88-97, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier

32. Evaluation of biocompatibility of random or aligned electrospun polyhydroxybutyrate scaffolds combined with human mesenchymal stem cells

KOSE S., AERTS KAYA F. S. F., DENKBAŞ E. B., KORKUSUZ P., ÇETİNKAYA F. D.
TURKISH JOURNAL OF BIOLOGY , vol.40, no.2, pp.410-419, 2016 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

33. Hematopoetik ve Mezenkimal Kök Hücreler

AERTS KAYA F. S. F., ÇELEBİ SALTIK B.
Turkiye Klinikleri J Plast Surg-Special Topics , vol.4, no.3, pp.11-18, 2015 (Non Peer-Reviewed Journal)

34. Structural investigation of donor age effect on human bone marrow mesenchymal stem cells: FTIR spectroscopy and imaging

Aksoy C., Kaya F. A., KUŞKONMAZ B. B., Uckan D., Severcan F.
AGE , vol.36, no.4, 2014 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

35. 5-Androstene-3 beta,17 beta-diol Promotes Recovery of Immature Hematopoietic Cells Following Myelosuppressive Radiation and Synergizes With Thrombopoietin

Aerts-Kaya F. S. F., Visser T. P., Arshad S., Frincke J., Stickney D. R., Reading C. L., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.84, no.3, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

36. Keratinocyte Growth Factor and Stem Cell Factor to Improve Thymopoiesis after Autologous CD34(+) Cell Transplantation in Rhesus Macaques

Wils E., Aerts-Kaya F. S. F., Rombouts E. J. C., van Mourik I., Rijken-Schelen A., Visser T. P., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.18, no.1, pp.55-65, 2012 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

37. Mobilization of Hepatic Mesenchymal Stem Cells From Human Liver Grafts

Pan Q., Fouraschen S. M. G., Kaya F. S. F. A., Verstegen M. M., Pescatori M., Stubbs A. P., et al.
LIVER TRANSPLANTATION , vol.17, no.5, pp.596-609, 2011 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

38. Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype

van Til N. P., Stok M., Kaya F. S. F. A., de Waard M. C., Farahbakhshian E., Visser T. P., et al.
BLOOD , vol.115, no.26, pp.5329-5337, 2010 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

39. Mesenchymal stem cell studies in children with inherited diseases: A proposal for identification of candidate diseases for mesenchymal stem cell therapies (PEDI-STEM project)

Uckan D., Kilic E., Aerts F. S. F., Cetin M., Gumruk F., Tezeaner A.
CYTOTHERAPY , vol.8, 2006 (SCI-Expanded, Scopus) identifier
Papers Presented at Peer-Reviewed Scientific Conferences 125

1. Non-myelotoxic agents can be used as conditioning before hematopoietic stem cell gene therapy

ŞEKER M. E., EROL DUYAR Ö. D., PERVİN B., AERTS KAYA F. S. F.
18. Tıbbi biyoloji ve genetik kongresi, Ankara, Turkey, 26 - 29 October 2023, vol.2, (Summary Text)

2. In vitro modeling of acute graft versus host disease using Rag2-/- mouse colonoids

PERVİN B., GİZER M., Sarı İ., GÜR S. N., POLAT E. G., ŞEKER M. E., et al.
18. Tıbbi biyoloji ve genetik kongresi, 26 - 29 October 2023, vol.2, pp.48, (Summary Text)

3. CXCR4 expression is critical for migration of BM-MSCs, but not for regeneration of intestinal damage

PERVİN B., GİZER M., ŞEKER M. E., EROL DUYAR Ö. D., DEĞİRMENCİ UZUN B., KORKUSUZ P., et al.
18. Tıbbi biyoloji ve genetik kongresi, 26 - 29 October 2023, vol.2, pp.46, (Summary Text)

4. RAB27A Gen Tedavisinin Olası Tümorijenik Etkilerinin İncelenmesi

EROL DUYAR Ö. D., ŞEKER M. E., PERVİN B., ÖZÇİMEN B., ŞENOCAK Ş., GİZER M., et al.
18. Tıbbi biyoloji ve genetik kongresi, 26 - 29 October 2023, vol.2, pp.15, (Summary Text)

5. Hematopoietik kök hücre gen tedavisine hazırlık rejimi olarak miyelotoksik olmayan ilaçların kullanılması

ŞEKER M. E., EROL DUYAR Ö. D., PERVİN B., AERTS KAYA F. S. F.
49 Yıllık THD kongresi, 01 November 2023 - 05 February 0023, (Summary Text)

6. The role of in vitro and in vivo models in the development of gene therapy for immune deficiencies

AERTS KAYA F. S. F.
18. Tıbbi biyoloji ve genetik kongresi, 26 - 29 October 2023, (Summary Text)

7. Comparison of different methods for genetic correction of Griscelli Syndrome type II-derived stem cells

EROL DUYAR Ö. D., ŞEKER M. E., PERVİN B., ÖZÇİMEN B., ŞENOCAK Ş., GÜR S. N., et al.
EHA annual meeting 2023, 08 June 2023, vol.7, (Summary Text)

8. Non-Myelotoxic Chemicals As A Preparatory Regimen For Hematopoietic Stem Cell Gene Therapy

ŞEKER M. E., EROL DUYAR Ö. D., PERVİN B., Wagemaker G., van Til N. P., AERTS KAYA F. S. F.
EHA annual meeting 2023, 08 June 2023, vol.7, (Summary Text)

9. Correction of RAB27A from Griscelli Syndrome Type II-derived Mesenchymal Stem Cells

EROL DUYAR Ö. D., ŞEKER M. E., AERTS KAYA F. S. F.
ESGCT 2021 annual congress, 19 - 22 October 2021, vol.32, (Summary Text)

10. Neuropeptide Y plays a role in the regulation of proliferation and quiescence of HSCs

EROL Ö. D., ŞEKER M. E., PERVİN B., B. U., ÖZYÜNCÜ Ö., YANIK T., et al.
İstiniye Üniversitesi Kök Hücre ve Doku Mühendisliği Sempozyumu, Çevrimiçi, Turkey, 27 - 28 February 2021, (Summary Text)

11. Hematopoetik Kök Hücre Naklinde Alıcıya Zarar Vermeyen Hazırlık Rejimlerinin Geliştirilmesi

ŞEKER M. E., EROL Ö. D., PERVİN B., AERTS KAYA F. S. F.
İstiniye Üniversitesi Kök Hücre ve Doku Mühendisliği Sempozyumu, Çevrimiçi, Turkey, 27 - 28 February 2021, (Summary Text)

12. Repair of Griscelli Type 2 mesenchymal stem cells with a lentiviral vector carrying RAB27Aco

Erol Ö. D., Şeker M. E., Pervin B., Van Til N. P., Günel_Özcan A., Kocaefe Y. Ç., et al.
İstiniye Üniversitesi Kök Hücre ve Doku Mühendisliği Sempozyumu, İstanbul, Turkey, 27 - 28 February 2021, (Summary Text)

13. Non-Enzymatic Dissociation Methods Preserve CXCR4 Expression of Mesenchymal Stem Cells

Pervin B., Aydın G., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
İstiniye Üniversitesi Kök Hücre ve Doku Mühendisliği Sempozyumu, Çevrimiçi, Turkey, 27 - 28 February 2021, (Summary Text)

14. Role of Neuropeptide Y (NPY) in Regulating Hematopoietic Stem Cells.

Ulum B., Mammadova A., ÖZYÜNCÜ Ö., ÇETİNKAYA F. D., YANIK T., AERTS KAYA F. S. F.
NIAID 13. annual fellows workshop, 13 November 2019, (Summary Text)

15. Short-term hypothermic storage supports maintenance of transplantable hematopoietic stem cells.

AERTS KAYA F. S. F., Pervin b., Mammadova A., Wagemaker G., ÇETİNKAYA F. D.
55. SLTB Congress Seville, Spain 2019, 2 - 04 October 2019, (Summary Text)

16. Östrojen reseptör pozitif MCF7 meme kanseri hücre hattı üzerine doğal biyoaktif bileşenlerden timokinon, kafeik asit fenetil ester fukoidanın antikanser etkilerinin karşılaştırmalı analizi.

Eroğlu Köksal E., BALTA G., AERTS KAYA F. S. F.
23. Ulusal Kanser Kongresi 2019, Turkey, 17 - 21 April 2019, pp.319, (Summary Text)

17. Hematopoetik kök hücre regülasyonunda Nöropeptid Y (NPY)´in rolünün incelenmesi

Ulum B., Mammadova A., ÖZYÜNCÜ Ö., ÇETİNKAYA F. D., YANIK T., AERTS KAYA F. S. F.
3. Kök Hücre ve Hücresel Tedaviler Kongresi, Turkey, 12 - 14 April 2019, pp.137, (Summary Text)

18. RAG2-/- ağır kombine immün yetmezliği hematopoetik kök hücre nakli ve gen tedavi optimizasyonu.

Pervin b., Erol Ö. D., ÇETİNKAYA F. D., Wagemaker G., AERTS KAYA F. S. F.
3. Kök Hücre ve Hücresel Tedaviler Kongresi 2019, Turkey, 12 - 14 April 2019, pp.67, (Summary Text)

19. Griscelli Tip 2 Mezenkimal Kok Hucrelerden Uyarılmış Pluripotent Kök Hücre Geliştirilmesi ve in vitro Hematopoetik Farklılasması.

Güney Esken G., erol ö. d., BİLGİÇ E., KORKUSUZ P., gürhan sevinç g., ÖNDER T. T., et al.
3. Kök Hücre ve Hücresel Tedaviler Kongresi 2019, Turkey, 12 - 14 April 2019, pp.72, (Summary Text)

20. Doğal biyoaktif timokinon, kafeik asit fenetil ester ve fukoidan bileşenleri anti-meme kanseri aktivitelerinin triple-negatif MDA-MB-231 hücrelerinde araştırılması.

Eroğlu Köksal E., BALTA G., AERTS KAYA F. S. F.
3. Kök Hücre ve Hücresel Tedaviler Kongresi 2019, Turkey, 12 - 14 April 2019, pp.141, (Summary Text)

21. D-Ala2,D-Leu5,Enkefalin hematopoetik kök hücreleri in vitro oksidatif stres ve endoplasmik retikulum stresten korumaktadır.

Mammadova A., Ulum B., ÖZYÜNCÜ Ö., AERTS KAYA F. S. F.
3. Kök Hücre ve Hücresel Tedaviler Kongresi, Turkey, 12 - 14 April 2019, pp.66, (Summary Text)

22. Development and Differentiation of Induced Pluripotent Stem Cells from Griscelli type 2 patients

Güney Esken G., Erol Ö. D., AERTS KAYA F. S. F.
20. NvGT 2019 annual meeting, 6 - 09 March 2019, pp.14-15, (Summary Text)

23. The NPY-Y1 receptor for neuropeptide Y is highly expressed on hematopoietic stem cells from bone marrow and cord blood

Ulum B., Guney-Esken G., ÖZYÜNCÜ Ö., Uckan-Cetinkaya D., YANIK T., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy, Lausanne, Switzerland, 16 - 19 October 2018, vol.29, (Summary Text) identifier

24. Hematopoietic differentiation of induced pluripotent stem cells derived from patients with Griscelli syndrome type 2

Guney-Esken G., Gurhan G., Onder T., Uckan-Cetinkaya D., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy, Lausanne, Switzerland, 16 - 19 October 2018, vol.29, (Summary Text) identifier

25. Mezenkimal Kök Hücreler Endokannabinoidler Aracılığı ile Hematopoietik Kök Hücre Mobilizasyonunu Düzenlemektedir

KÖSE S., KÖPRÜ Ç. Z., KARAOSMANOĞLU B., TAŞKIRAN Z. E., AERTS KAYA F. S. F., NEMUTLU E., et al.
Elektron Mikroskobu Kongresi, Turkey, 24 - 26 April 2019, (Full Text)

26. TGF-beta 1 Production By Bone Marrow Mesenchymal Stem Cells of FANCD2 Differs from Other Fanconi Anemia Complementation Groups

Cagnan I., Gunel-Ozcan A., Aerts-Kaya F. S. F., Ameziane N., Kuskonmaz B., Dorsman J., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text) identifier

27. PKNOX2 regulated by TGFbeta is a new candidate to explain bone marrow failure in Fanconi Anemia.

Cagnan I., Aerts Kaya F. S. F., Coşgun E., Konu Karakayalı Ö., Kuşkonmaz B. B., Çetinkaya F. D., et al.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.136, (Summary Text)

28. Development and characterization of iPS cell lines from a patient with Griscelli type 2 disease.

Güney E. G., Pervin b., ŞAHAN Ö. B., ÇETİNKAYA F. D., ÖZCAN A., Schambach A., et al.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.135, (Summary Text)

29. Human Mesenchymal Stem Cells support B-cell and T-cell differentiation of cord blood CD34 cells under optimized conditions.

Visser T. P., van Til N., ÖZYÜNCÜ Ö., Wagemaker G., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.135, (Summary Text)

30. Hypothermic storage of Hematopoetic Stem Cells can be used as an alternative to short-term cryopreservation.

Visser T. P., Pervin b., ÇETİNKAYA F. D., Wagemaker G., AERTS KAYA F. S. F.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.136, (Summary Text)

31. Assessment Of ER Stress In Mesenchymal Stem Cells From Healthy And Obese Bone Marrow Donors.

Ulum B., Teker H. T., Balta G., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.135, (Summary Text)

32. Comparison of research grade and GMP grade serum-free media for ex vivo expansion of hematopoietic stem cells

Sharafi P., ÖZYÜNCÜ Ö., Johnston I., Uckan-Cetinkaya D., Wagemaker G., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text) identifier

33. Development of human cell lines that support in vitro B and T-cell differentiation of hematopoietic stem cells

Guney G., van Til N., ÖZYÜNCÜ Ö., Uckan-Cetinkaya D., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text) identifier

34. CD271+bone marrow cells support in vitro expansion and lymphopoietic differentiation of human CD34+hematopoietic stem cells

AYDIN G. B., ÖZYÜNCÜ Ö., Uckan-Cetinkaya D., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text) identifier

35. Optimization of methods for hypothermic preservation of primary human hematopoietic stem cells in culture

Sarikaya A., Visser T., ÖZYÜNCÜ Ö., Uckan-Cetinkaya D., Wagemaker G., Aerts-Kaya F. S. F.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text) identifier

36. Change in HOX gene expression by osteogenic differentiation capacity of human bone marrow derived mesenchymal stromal/stem cells

Cagnan I., Aerts-Kaya F. S. F., Uckan D., ÖZCAN A.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text) identifier

37. Obez Kemik İliği Mezenkimal Kök Hücrelerinin Endoplasmik Retikulum Stresi Yüksek ve Farklılaşma Kapasiteleri Düşüktür

Ulum B., Teker H. T., BALTA G., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, pp.70-71, (Summary Text)

38. İnsan Kemik İliğinde Rantes ve Reseptörlerinin İncelenmesi

KARAAĞAÇ AKYOL T., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
42. Ulusal Hematoloji Kongresi 2016, Antalya, Turkey, 19 - 22 October 2016, pp.69, (Summary Text)

39. Mesenchymal stem cells regulate the hematopoietic stem cell mobilization through the endocannabinoids.

KÖSE S., KÖPRÜ Ç. Z., KARAOSMANOĞLU B., Taşkıran E. Z., AERTS KAYA F. S. F., NEMUTLU E., et al.
ESGCT annual meeting 2016, 18 - 21 October 2016, vol.27, pp.1-185, (Summary Text)

40. Bone marrow derived CD271 cells support in vitro hematopoiesis.

AERTS KAYA F. S. F.
5. CELL-PID annual meeting 2016, 13 - 15 May 2016, (Summary Text)

41. Comparison of immunomodulatory and differentiation capacities of Mesenchymal Stem Cells derived from bone marrow and placental tissue

Sarıkaya A., Aydın G., ÖZYÜNCÜ Ö., Özbek E., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
XIII. Ulusal Histol ve Embriyol Kongresi, İzmir, Turkey, 30 April - 03 May 2016, pp.108-109, (Summary Text)

42. Mezenkimal Kök Hücreler Hematopoetik Kök Hücrelerin mobilizasyonunu Endokannabinoidler aracılığı ile düzenlemektedir.

KÖSE S., KÖPRÜ Ç. Z., KARAOSMANOĞLU B., TAŞKIRAN Z. E., AERTS KAYA F. S. F., NEMUTLU E., et al.
XIII. Ulusal Histol ve Embriyol Kongresi, İzmir, Turkey, 30 April - 03 May 2016, pp.89-90, (Summary Text)

43. Süt Çocukluğunun Geçici Hipogamaglobulinemisinde B Lenfosit Alt Grupları

Kara Eroglu F., Turul T., AERTS KAYA F. S. F., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ., Sanal Ö.
2. Klinik İmmünoloji Kongresi 2016, Turkey, 31 March - 03 April 2016, pp.19, (Summary Text)

44. Endoplasmic Reticulum Stress During Adipogenic Differentiation of Mesenchymal Stem Cells

Sarikaya A., Teker H. T., Ulum B., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
2. Int. Congress on Stem Cells and Cellular Therapies, Antalya, Turkey, 15 - 18 October 2015, pp.101, (Summary Text)

45. Prospectively isolated CD271+Mesenchymal Stem Cells support expansion of Hematopoietic Stem Cells with lymphohematopoietic differentiation potential

AYDIN G. B., Uckan-Cetinkaya D., Aerts-Kaya F. S. F.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text) identifier

46. Comparison of different serum-free media for in vitro expansion of Hematopoietic Stem Cells

Sharafi P., AYDIN G. B., Uckan-Cetinkaya D., Wagemaker G., Aerts-Kaya F. S. F.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text) identifier

47. Unmodified Mesenchymal Stem Cells do not support in vitro T-and B-Cell differentiation of Hematopoietic Stem Cells

Sharafi P., Cevher I., Gunel-Ozcan A., Uckan-Cetinkaya D., Aerts-Kaya F. S. F.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text) identifier

48. Endocannabinoids And Their Receptors Are Located On Human Bone Marrow Niche Mesenchymal Stem And Hematopoietic Progenitor Cells

KÖSE S., AERTS KAYA F. S. F., AKAR İ., NEMUTLU E., KOCAEFE Y. Ç., ÇETİNKAYA F. D., et al.
ISSCR annual meeting 2015, 24 - 27 June 2015, (Summary Text)

49. The Effect of Endoplasmic Reticulum (ER) Stress on Human Bone Marrow Derived Mesenchymal Stem Cells

Ulum B., AERTS KAYA F. S. F., Teker H. T., Balta G., ÇETİNKAYA F. D.
ISSCR annual meeting 2015, 24 - 27 June 2015, pp.1582, (Summary Text)

50. Current Concepts in Stem Cell Biology and Stem Cell types

AERTS KAYA F. S. F., Kansu E.
V. Int congress of Mol Med 2015, İzmir, Turkey, 20 - 22 May 2015, pp.20, (Summary Text)

51. Use of Mesenchymal Stem Cells as Feeder Cells to Support In Vitro T- and B-Cell Differentiation of Hematopoietic Stem Cells

Cevher İ., Sharafi P., Aydın G., ÖZCAN A., ÇETİNKAYA F. D., AERTS KAYA F. S. F.
V. Int congress of Mol Med 2015, İzmir, Turkey, 20 - 22 May 2015, pp.182, (Summary Text)

52. Comparison of different enzymatic and non-enzymatic methods on cell surface expression of CXCR4 by human CD34 Hematopoietic Stem Cells and Bone Marrow Mesenchymal Stem Cells.

Aydın G., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
EBMT annual meeting 2015, 22 - 25 March 2015, vol.50, pp.133, (Summary Text)

53. Gene expression of Notch receptors and ligands by human Mesenchymal Stem Cells from different tissues.

Aydın G., AERTS KAYA F. S. F., ÖZCAN A., ÇETİNKAYA F. D.
EBMT annual meeting 2015, 22 - 25 March 2015, vol.50, pp.144, (Summary Text)

54. Effects of Platelet Derived Growth Factor (PDGF) and PDGF-R inhibitors on proliferation, apoptosis and cell cycle of Mesenchymal Stem Cells

Guney G., Aerts-Kaya F. S. F., Uckan-Cetinkaya D.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, pp.5561, (Summary Text) identifier

55. Split Chimerism Between Nucleated and Red Blood Cells in a Beta Thalassemia Patient After Stem Cell Transplantation

OKUR F. V., Aerts-Kaya F. S. F., KUŞKONMAZ B. B., OKUR H., ÇETİN M., GÜMRÜK F., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text) identifier

56. Chemical inducers of Endoplasmic Reticulum (ER) Stress suppress proliferation and adipogenic differentiation of human Mesenchymal Stem Cells

Ulum B., Aerts-Kaya F. S. F., Teker H. T., BALTA G., Uckan-Cetinkaya D.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text) identifier

57. Ex vivo expansion of HSCs using different commercially available media and cytokines

AERTS KAYA F. S. F.
CELL-PID annual meeting 2015, 3 - 05 February 2015, (Summary Text)

58. Effect of Imatinib on Proliferation, Apoptosis and Expression of Platelet Derived Growth Factor Receptor By Mesenchymal Stem Cells

Aerts-Kaya F. S. F., Guney G., ÜNAL Ş., Uckan-Cetinkaya D.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

59. Gene expression of Notch receptors and ligands by plastic adherent and prospectively isolated MSCs

Aydin G., Aerts-Kaya F. S. F., Cagnan I., Guenel-Oezcan A., Uckan-Cetinkaya D.
ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, vol.25, (Summary Text) identifier

60. Effects of Platelet Derived Growth Factor (PDGF) on proliferation, apoptosis and PDGF-R expression by MSCs

Aerts-Kaya F. S. F., Gueney G., Uckan-Cetinkaya D.
ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, vol.25, (Summary Text) identifier

61. Hücre kültürü: Klinik uygulamalar I

AERTS KAYA F. S. F.
5. Dermatoimmünoloji ve Allerji Güz Okulu, Turkey, 18 - 21 September 2014, (Summary Text)

62. PLATELET DERIVED GROWTH-BB INHIBITS PROLIFERATION OF HUMAN BONE MARROW DERIVED MULTIPOTENT MESENCHYMAL STEM CELLS IN PRESENCE OF FETAL CALF SERUM AND RAPIDLY SUPPRESSES PDGF-RB EXPRESSION

AERTS KAYA F. S. F., Güney E. G., Aydın G., Dönmez R., Kuskonmaz B. B., ÇETİNKAYA F. D.
EHA annual meeting 2014, Milan, Italy, 12 - 15 June 2014, vol.99, pp.727, (Summary Text)

63. IMATINIB AND PLATELET DERIVED GROWTH FACTOR COOPERATE IN INHIBITION OF MESENCHYMAL STEM CELL PROLIFERATION AND SUPPRESSION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR EXPRESSION

AERTS KAYA F. S. F., Güney Esken G., Aydın G., Kuskonmaz B., ÇETİNKAYA F. D.
EHA annual meeting 2014, Milan, Italy, 12 - 15 June 2014, vol.99, pp.594-595, (Summary Text)

64. Sağlıklı insan kemik iliği mikroçevresi ve Mezenkimal Kök Hücrelerde Platelet-Derived Growth Factor (PDGF) ve Reseptörünün (PDGF-R) incelenmesi.

Güney Esken G., AERTS KAYA F. S. F., Aydın G., dönmez r., KUŞKONMAZ B. B., ÇETİNKAYA F. D.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, pp.30-31, (Summary Text)

65. Fankoni Anemili Hastaların Kemik İliği Mezenkimal Kök Hücrelerinde PREP2 Gen İfadesi Donörlere Oranla Düşüş Göstermektedir.

ÇAĞNAN I., Coşgun E., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., KUŞKONMAZ B. B., ÖZCAN A.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, (Summary Text)

66. Kemik iliğinden prospektif olarak izole edilen CD271 ve Plastik-Aderan Mezenkimal Kök Hücre özelliklerinin karşılaştırılması ve hematopoez destekleyeci özelliklerinin araştırılması.

Aydın G., AERTS KAYA F. S. F., Güney Esken G., ÇETİNKAYA F. D.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, pp.36-37, (Summary Text)

67. Polymeric scaffolds with different alignment and their interactions with bone marrow derived mesenchymal stem cells

KÖSE S., AERTS KAYA F. S. F., DENKBAŞ E. B., KORKUSUZ P., ÇETİNKAYA F. D.
1. Kök Hücre ve Hücresel Tedaviler Kongresi, Kocaeli, Turkey, 20 - 23 March 2014, (Summary Text)

68. Enzimatik ve non-enzimatik kaldırma yöntemlerin hematopoetik ve mezenkimal kök hücre yüzey reseptörlerin ve CXCR4 ifadelerine üzerine olan etkisi.

Aydın G., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, (Summary Text)

69. Sağlıklı insan Mezenkimal Kök Hücre farklılaşması, çoğalması ve PDGF-R ekspresyonu üzerinde İmatinib Mesylate’ın etkisi

Güney Esken G., AERTS KAYA F. S. F., Aydın G., KUŞKONMAZ B. B., ÇETİNKAYA F. D.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, pp.51-52, (Summary Text)

70. Bone marrow niche: the role of PDGF/PDGFR and in ex vivo expansion of hematopoietic stem cells

AERTS KAYA F. S. F.
CELL-PID annual meeting 2014, 25 - 27 February 2014, (Summary Text)

71. Expansion of hematopoietic stem/progenitor cells from bone marrow, peripheral blood and umbilical cord blood under serum-free conditions by co-culture with plastic adherent or CD271mesenchymal stromal cells

AERTS KAYA F. S. F., Aydın G., ÖZYÜNCÜ Ö., AYTAÇ EYÜPOĞLU Ş. S., ÇETİNKAYA F. D.
ESGCT annual meeting 2013, Madrid, Spain, 25 - 28 October 2013, vol.24, pp.90-91, (Summary Text)

72. Isolation and Characterization of Prospectively Isolated CD271Human Bone Marrow-derived Mesenchymal Stromal Cells

AERTS KAYA F. S. F., Aydın G., ÇETİNKAYA F. D.
ESGCT annual meeting 2013, Madrid, Spain, 25 - 28 October 2013, vol.24, pp.93, (Summary Text)

73. Sağlıklı insan kemik iliği endosteal ve santral bölgelerinde sitokin ekspresyonları ve G-CSF etkisi.

AERTS KAYA F. S. F., ÇAĞNAN I., KÖSE S., Aydın G., KUŞKONMAZ B. B., ÇETİNKAYA F. D.
39. Ulusal Hematoloji Kongresi 2013, Turkey, 23 - 26 October 2013, pp.42-43, (Summary Text)

74. Kemik iliğinden prospektif izolasyon yapılarak elde edilen CD271 Mezenkimal Stromal Hücrelerin in vitro hematopoezi destekleyici etkisi.

AERTS KAYA F. S. F., Aydın G., AYTAÇ EYÜPOĞLU Ş. S., ÇETİNKAYA F. D.
39. Ulusal Hematoloji Kongresi 2013, Turkey, 23 - 26 October 2013, pp.76-77, (Summary Text)

75. Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.

Cagnan I., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., Kuskonmaz B. B., ÇETİNKAYA F. D., ÖZCAN A.
ISSCR 2013, 15 - 18 September 2013, pp.37-38, (Summary Text)

76. ASSESSMENT OF HUMAN BONE MARROW PLASMA SAMPLES SUGGESTS A DIFFERENT ROLE FOR MESENCHYMAL STROMAL CELLS IN DISTINCT AREAS MEDIATED BY PDGF-BB/PDGF-R

AERTS KAYA F. S. F., Cagnan I., Aydın G., KÖSE S., Semerci A., Kuskonmaz B. B., et al.
ISEH annual meeting 2013, Vienna, Austria, 22 - 25 August 2013, vol.41, pp.61, (Summary Text)

77. Differential miRNA Expression Profile of Bone Marrow Derived Mesenchymal Stem Cells in Fanconi Anemia Patients and Healthy Donors

ÖZCAN A., Cagnan I., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., Kuskonmaz B., ÇETİNKAYA F. D.
ISEH annual meeting 2013, 22 - 25 August 2013, vol.41, pp.61, (Summary Text)

78. DIFFERENTIAL CYTOKINE EXPRESSION PROFILE OF HEALTHY HUMAN BONE MARROW PLASMA SAMPLES FROM THE ENDOSTEAL AND VASCULAR REGION

AERTS KAYA F. S. F., Kılıç E., Aydın G., KÖSE S., Cagnan I., GÜLTEKİN Ö., et al.
ISEH annual meeting 2013, Vienna, Austria, 22 - 25 August 2013, vol.41, pp.61, (Summary Text)

79. Polymeric Scaffolds with Different Alignment And Their Interactions With Bone Marrow-Derived Mesenchymal Stem Cells

KÖSE S., AERTS KAYA F. S. F., DENKBAŞ E. B., KORKUSUZ P., ÇETİNKAYA F. D.
ISEH annual meeting 2013, 22 - 25 August 2013, vol.41, pp.62, (Summary Text)

80. LACTIC ACID BACTERIA CAN REDUCE TLR-4 EXPRESSION ON INFLAMMATED GINGIVAL FIBROBLASTS AND MESENCHYMAL STEM CELLS IN VITRO

Mendi A., Kose S., Kaya F. A., Uckan D., YILMAZ D., Aral L.
42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), Vienna, Austria, 22 - 25 August 2013, vol.41, (Summary Text) identifier

81. IRON OXIDE NANOPARTICLE LABELING OF MESENCHYMAL STROMAL CELLS

Kilic E., Kaya F. A., Kose S., Anlar B., Uckan D.
42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), Vienna, Austria, 22 - 25 August 2013, vol.41, (Summary Text) identifier

82. EFFECTS OF IN-VIVO G-CSF STIMULATION ON CYTOKINE LEVELS IN BONE MARROW PLASMA SAMPLES FROM HEALTHY DONORS

Kaya F. S. F., Kose S., Aydin G., Cagnan I., BOCUTCU S., KUŞKONMAZ B. B., et al.
42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), Vienna, Austria, 22 - 25 August 2013, vol.41, (Summary Text) identifier

83. Differential levels of cytokines in the vascular and endothelial bone marrow niches of G-CSF stimulated and unstimulated human donors.

AERTS KAYA F. S. F.
CELL-PID annual meeting 2013, 19 - 22 February 2013, (Summary Text)

84. HOX-TALE genes show highly conserved yet heterogeneous expression profiles among fanconi anemia patients and healthy donors

ÇAĞNAN I., KONU KARAKAYALI Ö., AERTS KAYA F. S. F., KUŞKONMAZ B. B., ÇETİNKAYA F. D., ÖZCAN A.
HOX and TALE Transcription Factors in Development and Disease, Madrid, Spain, 28 November 2012 - 01 December 2010, pp.53, (Summary Text)

85. Expression of HOX genes in the bone marrow derived mesenchymal stromal/stem cells from Fanconi anemia patients changes following bone marrow transplantation.

ÖZCAN A., Cagnan I., KUŞKONMAZ B. B., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
ISSCR annual meeting 2012, 13 - 16 June 2012, vol.1, pp.126, (Summary Text)

86. Kök Hücre Gen Terapisinde İmmün Cevap

AERTS KAYA F. S. F., ÇETİNKAYA F. D.
1. Kök Hücre Araştırmaları Kongresi 2011, Turkey, 28 September - 02 October 2011, (Summary Text)

87. Sağlıklı donörlerden elde edilen mezenkimal kök hücrelerin sayı ve kalitesi üzerine donor yaşının etkisi

AERTS KAYA F. S. F., KÖSE S., ÇETİNKAYA F. D.
1 Uluslararası katılımlı Kök Hücre Sempozyumu 2010, Samsun, Turkey, 29 September - 01 October 2010, pp.62, (Summary Text)

88. Hastalıkta Ve Sağlıkta Mezenkimal Kök Hücrelerin MIRNA İfadeleri

ÖZCAN A., Kılıç E., AERTS KAYA F. S. F., ÇETİN M., ÇETİNKAYA F. D.
1. Uluslararası Katılımlı Kök Hücre Sempozyumu 2010, Samsun, Turkey, 29 September - 01 October 2010, pp.59, (Summary Text)

89. Mukolipidozis Tip Ii’ Hastalığında Kemik İliği Kökenli Mezenkimal Kök Hücrelerin Elde Edilmesi Ve Karakterizasyonu

KÖSE S., KUŞKONMAZ B. B., AERTS KAYA F. S. F., Kılıç E., ÇETİN M., Coşgun T., et al.
2. Lizozomal Hastalıklar Kongresi 2010, Turkey, 29 - 30 April 2010, pp.68, (Summary Text)

90. Effects of immune modulation on the risk assessment of gene therapy

AERTS KAYA F. S. F., kaptein l., Wagemaker G.
11. NVGT Spring Symposium 2010, 11 - 12 March 2010, pp.14, (Summary Text)

91. Demir partikülleri ile işaretli insane mezenkimal kök hücrelerin immünolojik özellikleri ve preliminer hayvan modellerinde in vivo hücre takibi.

Kılıç E., AERTS KAYA F. S. F., bozkurt g., ANLAR F. B., AZKUR A. K., KORKUSUZ P., et al.
6. Ulusal KİT ve Kök Hücre Tedavileri Kongresi 2010, Turkey, 4 - 06 March 2010, pp.142, (Summary Text)

92. Comparison of miRNA expression profile during adipocyte induction of mesenchymal stem cells from bone marrows of malignant infantile osteopetrosis patients and bone marrow donors reveals 15 differentially expressed miRNAs

Gunel-Ozcan A., KILIÇ E., Aerts-Kaya F. S. F., ÇETİN M., Uckan D.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45, (Summary Text) identifier

93. Culture of mesenchymal stem cells in presence of human platelet lysate as an alternative for animal-derived serum

Aerts-Kaya F. S. F., Arslan S., Uckan D.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45, (Summary Text) identifier

94. Kordon kanından Mezenkimal Kök Hücre İzolasyonu

AERTS KAYA F. S. F.
1. Ulusal Mezenkimal Kök Hücre Sempozyumu, Turkey, 5 - 06 February 2010, (Summary Text)

95. ‘I-Cell’ hastalığında kemik iliği kökenli mezenkimal kök hücrelerin karakterizasyonu

KÖSE S., KUŞKONMAZ B. B., AERTS KAYA F. S. F., Kılıç E., ÇETİN M., Coşgun T., et al.
6. Ulusal KIT ve Kök Hücre Tedavileri Kongresi 2010, Turkey, 4 - 06 March 2010, pp.141, (Summary Text)

96. LENTIVIRAL GENE THERAPY OF MURINE HEMATOPOIETIC STEM CELLS LEADS TO CORRECTION OF THE POMPE DISEASE PHENOTYPE

Stok M., van Til N., AERTS KAYA F. S. F., Farahbakhshian E., Visser T. P., Kroos M. A., et al.
CLINICAL THERAPEUTICS, Munich, Germany, 20 - 21 November 2009, vol.32, pp.81, (Summary Text)

97. Lessons from non-gene therapy studies to predict the environmental risk in immune modulation gene therapy

Aerts-Kaya F. S. F., Kaptein L., Wagemaker G.
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Germany, 21 - 25 November 2009, vol.20, pp.1470-1471, (Summary Text) identifier

98. Osteopetrosis hastalarının kemik iliği kaynaklı mezenkimal kök hücrelerinin adipojenik farklılaşmalarında rol oynayan miRNA ekspresyon profilinin saptanması.

ÖZCAN A., Kılıç E., AERTS KAYA F. S. F., ÇETİN M., ÇETİNKAYA F. D.
XI. Ulusal Tıbbi Genetik ve Biyolojisi Kongresi 2009, Turkey, 28 - 31 October 2009, (Summary Text)

99. HUMAN LIVER HEMATOPOIETIC STEM CELLS HAVE A MULTI-POTENT AND SELF-RENEWAL CAPACITY AND MAY FUNCTION AS LOCAL PROGENITORS FOR LIVER-RESIDENT LEUKOCYTES

Pan Q., Aerts-Kaya F. S. F., Kazemier G., Kwekkeboom J., Metselaar H. J., Tilanus H. W., et al.
15th Annual Congress of the International-Liver-Transplantation-Society, New-York, United States Of America, 8 - 11 July 2009, vol.15, (Summary Text) identifier

100. MOBILIZATION, IMMUNOMODULATION AND HEPATIC DIFFERENTIATION OF HUMAN GRAFT MESENCHYMAL STEM CELLS IN LIVER TRANSPLANTATION

Pan O., Fouraschen S. M. G., Aerts-Kaya F. S. F., van der Sloot A., Kazemier G., Kwekkeboom J., et al.
15th Annual Congress of the International-Liver-Transplantation-Society, New-York, United States Of America, 8 - 11 July 2009, vol.15, (Summary Text) identifier

101. Human Liver Grafts Contains Multi-Potent Hematopoietic Stem Cells with Self-Renewal Capacity Which Mobilize and Circulate in the Recipient after Transplantation

Pan Q., AERTS KAYA F. S. F., Arshad S., Verstegen M. M., Kwekkeboom J., Metselaar H., et al.
9th Joint Meeting of the ASTS/AST 2009, 29 May - 03 June 2009, vol.9, pp.464, (Summary Text)

102. Influence of Immune Modulation Gene Therapy on Environmental Risk Assessment

AERTS KAYA F. S. F., Leonie K., Wagemaker G.
MOLECULAR THERAPY, San Diego, 27 - 30 May 2009, vol.17, pp.381-382, (Summary Text)

103. Kök Hücre Genetik Modifikasyonlarının Biyogüvenlik ve Risk Değerlendirmesi

ÖZCAN A., AERTS KAYA F. S. F., ÇETİNKAYA F. D.
1. Ulusal Hücresel Tedavi ve Rejeneratif Tıp Kongresi, Kapadokya, Turkey, 5 - 08 March 2009, pp.103, (Summary Text)

104. İnsan kaynaklı mezenkimal kök hücrelerin demir oksit partikülleri ile işaretlenmesi.

Kılıç E., ANLAR F. B., AZKUR A. K., KÖSE S., AERTS KAYA F. S. F., Yörübulut M., et al.
1. Ulusal Hücresel Tedavi ve Rejeratif Tıp Kongresi 2009, Turkey, 5 - 08 March 2009, pp.106, (Summary Text)

105. Osteopetrosisli hastalardan izole edilen mezenkimal kök hücrelerde adiposit farklılaşma defekti

ÇETİNKAYA F. D., Kılıç E., Sharafi P., Kazık M., AERTS KAYA F. S. F., ERDEMLİ E., et al.
1. Ulusal Hücresel Tedavi ve Rejeratif Tıp Kongresi 2009, Turkey, 5 - 08 March 2009, pp.104, (Summary Text)

106. Mobilization, Immunomodulation and Hepatic Differentiation of Graft-Resident Human Mesenchymal Stem Cells in Liver Transplantation.

Pan Q., Fouraschen S. M. G., Aerts-Kaya F. S. F., Verstegen M. M. A., van der Sloot A., Smits R., et al.
9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, Massachusetts, United States Of America, 30 May - 03 June 2009, vol.9, pp.464, (Summary Text) identifier

107. Transplanted CD34 cells stimulated with Flt3 ligand and Granulocyte-Colony Stimulating Factor display an impaired early reconstitution capacity.

AERTS KAYA F. S. F., Hartong S., Visser T. P., Verstegen M. M., wognum a., Wagemaker G.
ASH annual meeting 2008, 6 - 09 December 2008, vol.112, pp.4591, (Summary Text)

108. 5-Androstene-3b,17b-Diol Administration of Mice Exposed to Total Body Irradiation Results in Rapid Reconstitution of Immature Bone Marrow Progenitor Cells and Synergizes with Thrombopoietin but Not with Granulocyte-Colony Stimulating Factor.

AERTS KAYA F. S. F., Visser T. P., Reading C. L., Frincke J., Stickney D., Wagemaker G.
ASH annual meeting 2008, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.811, (Summary Text)

109. HUMAN LIVER GRAFTS CONTAIN MULTI-POTENT HEMATOPOIETIC STEM CELLS WITH SELF-RENEWAL CAPACITY WHICH MOBILIZE AND CIRCULATE IN THE RECIPIENT AFTER LIVER TRANSPLANTATION

Pan Q., AERTS KAYA F. S. F., Arshad S., Verstegen M. M., Kwekkeboom J., Metselaar H., et al.
HEPATOLOGY, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48, pp.618-619, (Summary Text)

110. Mesenchymal stem cells are present in adult human liver and mobilized during cold storage of liver grafts at the time of transplantation.

Pan Q., AERTS KAYA F. S. F., Chikhovskaya j., van der Sloot A., scot h., smits r., et al.
AASLD annual meeting 2008, 31 October - 01 November 2008, vol.48, pp.643, (Summary Text)

111. Mesenchymal stem cells from osteopetrosis patients display a defect in adipocyte differentiation

ÇETİNKAYA F. D., Kılıç E., Kazık M., Sharafi P., AERTS KAYA F. S. F., CAN A., et al.
ISCT 2008 1. regional meeting, 14 - 16 September 2008, pp.130, (Summary Text)

112. Recombinant spider silk fibres allow expansion of hematopoietic stem cells and can serve as biomatrices for adherence of mesenchymal stem cells

AERTS KAYA F. S. F., Hedhammar M., Visser T. P., Arshad S., Engstrom W., Johansson J., et al.
ISCT 2008 1. regional meeting, 14 - 18 September 2008, pp.141, (Summary Text)

113. HUMAN ADULT LIVER CONTAINS MESENCHYMAL STEM CELLS WHICH ARE MOBILIZED DURING GRAFT PERFUSION AT TIME OF LIVER TRANSPLANTATION.

Pan Q., AERTS KAYA F. S. F., Chikhovskaya j., scot h., Janssen H., Kwekkeboom J., et al.
ILTS annual meeting 2008, Paris, France, 9 - 12 July 2008, vol.14, pp.234, (Summary Text)

114. HUMAN LIVER GRAFT CONTAINS HEMATOPOIETIC STEM CELLS WHICH ARE MOBILIZED DURING LIVER TRANSPLANTATION: CONTRIBUTION TO CHIMERISM?

Pan Q., AERTS KAYA F. S. F., Janssen H., Kwekkeboom J., Kazemier G., Tilanus H., et al.
ILTS annual meeting 2008, Paris, France, 9 - 12 July 2008, vol.14, pp.191, (Summary Text)

115. LENTIVIRAL GENE THERAPY OF HEMATOPOIETIC STEM CELLS RESULTS IN PHENOTYPE CORRECTION IN A MOUSE MODEL OF POMPE DISEASE

Stok M., van Til N., AERTS KAYA F. S. F., Visser T. P., Kroos M. A., de Waard M., et al.
EHA annual meeting 2008, Copenhagen, 12 - 15 June 2008, vol.93, pp.169, (Summary Text)

116. 5-ANDROSTENE-3 beta,17 beta-DIOL ADMINISTERED TO MICE EXPOSED TO TOTAL BODY IRRADIATION RESULTS IN RAPID RECONSTITUTION OF IMMATURE BONE MARROW PROGENITOR CELLS AND SYNERGIZES WITH TPO BUT NOT WITH G-CSF

AERTS KAYA F. S. F., Visser T. P., Reading C. L., Frincke J., Stickney D., Wagemaker G.
EHA annual meeting 2008, Copenhagen, 12 - 15 June 2008, vol.93, pp.113, (Summary Text)

117. EFFICACY OF RECOMBINANT HUMAN AND RHESUS THROMBOPOIETIN STIMULATED BLOOD TRANSFUSIONS IN COMPARISON TO UNSTIMULATED WHOLE BLOOD OR THROMBOCYTE TRANSFUSIONS IN A NON-HUMAN PRIMATE MODEL

Kaya F. S. F., Visser T. P., Hartong S. C. C., Agur Z., Wagemaker G.
13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.154, (Summary Text) identifier

118. Safety assessment in murine recipients of hematopoietic cells transduced with gammaretroviral or lentiviral vectors: evidence for significantly reduced genotoxicity of SIN lentiviral vectors.

van Til N., sarwari r., AERTS KAYA F. S. F., Visser T. P., Verstegen M. M., Wagemaker G.
ASGT annual meeting 2008, 30 May - 02 June 2008, vol.16, pp.361, (Summary Text)

119. Cell density and viral vector load are determinant factors for Ex vivo lentiviral transduction efficiency of hematopoietic stem cells

van Til N., AERTS KAYA F. S. F., Visser T. P., Wagemaker G., Verstegen M. M.
ESGCT annual meeting 2007, Rotterdam, Netherlands, 27 - 30 October 2007, vol.18, pp.1010, (Summary Text)

120. Cell-density and viral vector load are determinant factors for the ex vivo lentiviral transduction efficiency of hematopoietic stem cells

van Til N., Verstegen M. M., oerlemans c., AERTS KAYA F. S. F., Visser T. P., Wagemaker G.
ASGT annual meeting 2007, 30 May - 03 June 2007, vol.15, pp.397, (Summary Text)

121. HE2100 (5-Androstene-3b,17b-diol) after Cytoreductive Total Body Irradiation of Rhesus Monkeys Promotes the Recovery of Immature CD34 Bone Marrow Cells, Accelerates Platelet, Granulocyte and Red Cell Reconstitution, and Alleviates Neutropenia and Anemia

AERTS KAYA F. S. F., Visser T. P., Reading C. L., Frincke J., Verstegen M. M., Stickney D., et al.
ASH annual meeting 2005, 10 - 13 December 2005, vol.106, pp.131, (Summary Text)

122. HE2100 (5-androstene-3 beta,17 beta-diol) after cytoreductive total body irradiation of rhesus monkeys promotes the recovery of immature CD34+bone marrow cells, accelerates platelet, granulocyte and red cell reconstitution, and alleviates neutropenia and anemia

Kaya-Aerts F. S. F., Visser T., Reading C., Frincke J., Verstegen M., Stickney D., et al.
47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 10 - 13 December 2005, vol.106, (Summary Text) identifier

123. Mesenchymal stem cell differentiation defect in malignant infantile osteopetrosis

Kazık M., AERTS KAYA F. S. F., Kılıç E., TEZCANER A., OKUR H., Uckan-Cetinkaya D.
30 th International Society of Hematology World Congres 2005, İstanbul, Turkey, 28 September - 02 October 2005, vol.22, pp.176, (Summary Text)

124. Characterization of bone marrow-derived mesenchymal stem cells from healthy marrow donors of pediatric age

AERTS KAYA F. S. F., Kılıç E., Kucukbayrak Ö., Kazık M., TEZCANER A., OKUR H., et al.
30 th International Society of Hematology World Congress 2005, İstanbul, Turkey, 28 September - 02 October 2005, vol.22, pp.181, (Summary Text)

125. Mesenchymal stem cell studies in children with inherited diseases: A proposal for identification of candidate diseases for mesenchymal stem cell therapies (Pedi-Stem Project).

ÇETİNKAYA F. D., Kılıç E., AERTS KAYA F. S. F., ÇETİN M., GÜMRÜK F., CAN A., et al.
ISCT annual meeting 2006, 4 - 07 May 2006, vol.8, pp.241, (Summary Text)
Books 10

1. Hematopoetik kök hücreler ve Hematopoez

AERTS KAYA F. S. F., Kansu E.
in: İç Hastalıkları Kitabı, volüm 2, Gürler İliçin, Kadir Biberoğlu, Gültekin Süleymanlar, Serhat Ünal, Editor, Güneş Tıp Kitapevleri Yayınevi, pp.1477-1486, 2023

2. Generation and Hematopoietic Differentiation of Mesenchymal Stromal/Stem Cell-Derived Induced Pluripotent Stem Cell Lines for Disease Modeling of Hematopoietic and Immunological Diseases

Güney-Esken G., Aerts Kaya F. S. F.
in: Methods in Molecular Biology, Kursad Turksen, Editor, Springer, London/Berlin , Berlin, pp.1-21, 2021

3. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenge

Kose S., Aerts-Kaya F. S. F., ÇETİNKAYA F. D., Korkusuz P.
in: Advances in Experimental Medicine and Biology, Kursad Turksen, Editor, Springer, pp.135-162, 2021

4. Stem Cell Applications In Lysosomal Storage Disorders: Progress And Ongoing Challenges.

KÖSE S., AERTS KAYA F. S. F., ÇETİNKAYA F. D., KORKUSUZ P.
in: Advances in Experimental Medicine and Biology series, Cell Biology and Translational Medicine, Kürsad Türksen, Editor, Springer, pp.1-28, 2021

5. Neurological regulation of the bone marrow niche

AERTS KAYA F. S. F., Ulum B., Mammadova A., KÖSE S., Aydın G., KORKUSUZ P., et al.
in: Cell Biology and Translational Medicine Volume 6, Kursad Türkşen, Editor, Springer, pp.127-153, 2020

6. Kalp yetmezliğinde kök hücre uygulamaları

AERTS KAYA F. S. F., ÇETİNKAYA F. D.
in: Kalp yetmezliği Cep Kitabı, Oto A., Kaya E.B., Aytemir K., Editor, Erkem Tıbbi Yayıncılık, Ankara, pp.173-183, 2016

7. Radioprotective agents stimulating hematopoietic stem cell reconstitution. A translational approach.

AERTS KAYA F. S. F.
Optima Grafi Sche Communicatie, Rotterdam, 2010

8. Immune modulation in gene therapy studies. Points to consider for Environmental Risk Assessment.

AERTS KAYA F. S. F., Kaptein L., Wagemaker G.
Erasmus University, Rotterdam, 2010

9. Mesenchymal Stem Cell Engineering and Transplantation

AERTS KAYA F. S. F., Wagemaker G.
in: Genetic Engineering of Mesenchymal Stem Cells, Jan Nolta, Editor, Elsevier, pp.1-45, 2010

10. Mesenchymal stem cell engineering and transplantation

AERTS KAYA F. S. F., Wagemaker G.
in: Genetic engineering of mesenchymal stem cells, Nolta J.A., Editor, Elsevier Science, Oxford/Amsterdam , Amsterdam, pp.1-45, 2004
Other Publications 1

1. Göbek kordon kanı hayat kurtarabilir; atmayın, bankaya bağışlayın!

AERTS KAYA F. S. F.
Other, pp.26-30, 2018
Metrics

Publication

179

Publication (WoS)

64

Publication (Scopus)

33

Citation (WoS)

363

H-Index (WoS)

9

Citation (Scopus)

350

H-Index (Scopus)

9

Citation (Scholar)

615

H-Index (Scholar)

13

Citation (TrDizin)

2

H-Index (TrDizin)

1

Citation (Sobiad)

2

H-Index (Sobiad)

1

Citation (Sum Other)

2

Project

31

Thesis Advisory

10

Open Access

12
UN Sustainable Development Goals